Title of article
Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones Original Research Article
Author/Authors
Siavosh Mahboobi، نويسنده , , Andrea Uecker، نويسنده , , Christophe Cénac، نويسنده , , Andreas Sellmer، نويسنده , , Emerich Eichhorn، نويسنده , , Sigurd Elz، نويسنده , , Frank-D. B?hmer، نويسنده , , Stefan Dove، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2007
Pages
11
From page
2187
To page
2197
Abstract
A series of bis(benzo[b]furan-2-yl)methanones was synthesized and tested for inhibition of FLT3 and PDGFR autophosphorylation. Mostly, C-5 substitution leads to PDGFR selectivity, which was strongest in the case of the 5,5′-dimethoxy derivative. The 5,5′-diamino and the 6,6′-dihydroxy compounds are more active at FLT3. At both kinases, the potency of the best inhibitors approaches IC50 values of ca. 0.5 μM. Molecular modeling studies suggest that the bisbenzofuranylmethanones are able to fit into the same binding site as their indolyl analogues which have been suggested to form a bidentate hydrogen bridge with the backbone in the hinge regions. The loss of one H bond by the NH–O exchange might be partially compensated by, for example, the weak interaction of one furanyl oxygen with FLT3 Cys-828.
Keywords
Bisbenzofuranylmethanone , Receptor tyrosine kinase , FLT3 , PDGFR , Bisindolylmethanone , Benzofuranylindolylmethanone
Journal title
Bioorganic and Medicinal Chemistry
Serial Year
2007
Journal title
Bioorganic and Medicinal Chemistry
Record number
1305424
Link To Document